Infrequent false positive [(18)F]flutemetamol PET signal is resolved by combined histological assessment of neuritic and diffuse plaques

BACKGROUND: The performance of [(18)F]flutemetamol amyloid PET against histopathological standards of truth was the subject of our recent article in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring (2017;9:25–34). MAIN BODY: This viewpoint article addresses infrequently obs...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Alzheimers Res Ther
Päätekijät: Ikonomovic, Milos D., Fantoni, Enrico R., Farrar, Gill, Salloway, Stephen
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: BioMed Central 2018
Aiheet:
Viewpoint
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6015459/
https://ncbi.nlm.nih.gov/pubmed/29935545
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13195-018-0387-6
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia